← Evidence map

ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.

Luke M Tomasovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37999893